Open AccessS1696 Vedolizumab Treatment of Refractory Immune Checkpoint Inhibitor Colitis
Author(s) -
Bridgette B. McNally,
Angiela Sivakumar,
Nael Haddad,
Sakolwan Suchartlikitwong,
Paul Muńa Aguon,
Brian M. Fung,
Kelly Zucker,
Joseph David
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000780316.76780.1f
Subject(s) - medicine , infliximab , vedolizumab , colitis , ipilimumab , gastroenterology , adverse effect , diarrhea , prednisone , ulcerative colitis , surgery , cancer , immunotherapy , tumor necrosis factor alpha , disease